CEMIP and neoplasm: Remarkably, a small group of patients with tumours strongly expressing KIAA1199 in the nucleus accompanied by weak cytoplasmic expression (Figure 1d) had a significantly (log-rank test P-value 0.02) better outcome compared with those with strong cytoplasmic, or nuclear and cytoplasmic KIAA1199 expression using Kaplan–Meier survival estimates of disease-free survival (Figure 1e).